Antimicrobial resistance occurs when microbes (bacteria, viruses, fungi and parasites) become resistant to antimicrobial drugs (such as antibiotics, anti-fungals, antivirals, antimalarials, and anthelmintics).As a result, the medicines become ineffective and infections persist in the body, increasing the risk of spread to others.India has witnessed an increase in antibiotic consumption- about 65 per cent in 2015 compared to 2000, while the rate of consumption increased from 3.2 to 6.5 billion daily defined doses (DDDs) in the same period. Recently, government has banned colistin- a last line of antibiotic in the poultry industry due to rise in cases of antibiotic resistance against it.
Various Causes of antibiotic resistance: Microbes can become resistant to drugs for both biological and social reasons.


|
Acinetobacter baumannii The U.S. Food and Drug Administration has approved Xacduro as a new treatment for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused by Acinetobacter baumannii-calcoaceticus complex (A. baumannii).
“Red alert” pathogen”
Locomotion
Impact
Habitat
|
Government initiative against AMR:
On the basis of the NAP, various states have begun the process of initiating their State Action Plans. The challenges in implementation of NAP are as varied perceptions about antibiotic use and AMR among key stakeholders, lack of diagnostic facilities, widespread use of antibiotics in various sectors, environmental contamination because of pharmaceutical industry, etc. Thus, inter-sectoral co-ordination between public and private sectors and comprehensive strengthening of the healthcare systems are necessary to achieve the desired forward momentum.
|
Medicines Patent Pool Agreement for Leukaemia Recently, the Medicines Patent Pool (MPP), a United Nations-backed group signed sub-licence agreements with three India-based companies to make certain Cancer Drugs more accessible and cheaper for patients. § These agreements allow the production of generic versions of Novartis'' cancer treatment drug Nilotinib, primarily used for Chronic Myeloid Leukaemia (CML), in several countries. § The licence covers India, seven middle-income countries, and 44 territories, allowing the generic versions of Nilotinib to be supplied, subject to local regulatory authorization. Medicines Patent Pool § MPP is a United Nations-backed public health organisation working to increase access to, and facilitate the development of, life-saving medicines for Low- and Middle-Income Countries (LMIC). § It was founded in July 2010, based in Geneva, Switzerland. § MPP partners with civil society, governments, international organisations, industry, patient groups, and other stakeholders, to prioritise and license needed medicines and pool Intellectual Property to encourage generic manufacture and the development of new formulations. § As of now, MPP has signed agreements with twelve patent holders for thirteen Human Immunodeficiency Virus (HIV) antiretrovirals, one HIV technology platform, three hepatitis C direct-acting antivirals, a tuberculosis treatment, a long-acting technology, two experimental oral antiviral treatments for Covid-19 and a Covid-19 serological antibody technology. Chronic Myeloid Leukaemia (CML) o It is one of the types of Leukemia, which is a blood-cell cancer that affects the bone marrow and the blood. Other types are, · Acute Lymphoblastic Leukemia (ALL) · Acute Myeloid Leukemia (AML) · Chronic Lymphocytic Leukemia (CLL). o It is characterized by the uncontrolled growth of abnormal white blood cells called myeloid cells. o CML typically progresses slowly, and it is often diagnosed during the chronic phase. § Diagnosis: o CML is typically diagnosed through a combination of blood tests and bone marrow examination. |
Prevention and control measures:
There is need to urgently address antimicrobial resistance through the lens of one (human, animal and environment) health. All countries need to work together to limit the spread of ARGs and antibiotics between humans, animals and the environment in the globalised world where we live. Even though national action plans have been laid down by most countries, these plans have yet to move from paper to the ground as antibiotics continue to be freely used.
PYQ
Which of the following are the reasons for the occurrence of multi-drug resistance in microbial pathogens in India? (2019)
1. Genetic predisposition of some people
2. Taking incorrect doses of antibiotics to cure diseases
3. Using antibiotics in livestock farming
4. Multiple chronic diseases in some people
Select the correct answer using the code given below.
(a) 1 and 2
(b) 2 and 3 only
(c) 1, 3 and 4
(d) 2, 3 and 4